Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

OXIS completes preclinicals of restenosis treatment

March 7, 1997

Watson's mexiletine approved

March 6, 1997

Dual NEP/ECE inhibitor for heart failure

March 6, 1997

Potential agent for hypertension and CHF from Roche Bioscience

March 6, 1997

Zeneca presents potent and selective ETA receptor antagonist

March 6, 1997

Senju prepares beta-blocker

March 6, 1997

Lp-PLA2 inhibitors disclosed by SKB

March 5, 1997

ET antagonists from Warner-Lambert

March 5, 1997

Antiarrhythmic agents reported by National Science Council

March 4, 1997

Preliminary phase II data on Xoma's Neuprex in trauma

March 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.